Use of rabies vaccines after reconstitution and storage

被引:14
作者
Khawplod, P
Tantawichien, T
Wilde, H
Limusanno, S
Tantawichien, T
Saikasem, A
Raksakate, S
机构
[1] Queen Saovabha Mem Inst, Thai Res Cross Soc, Bangkok 10330, Thailand
[2] King Chulalongkorn Univ Hosp, Dept Med, Bangkok 10330, Thailand
关键词
D O I
10.1086/324507
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Storing freshly reconstituted purified chick embryo rabies vaccine at 4 degreesC for 1 week allowed use of <1 ampoule of 1.0 mL for 1 patient for day 0, 3, and 7 immunizations, representing considerable savings in vaccine and also possibly allowing use of this cost-saving regimen in centers that see <1 rabies-exposed patient daily. The 90-day booster dose mandated in the current intradermal regimen may not be necessary if the day 28 dose is doubled, eliminating 1 clinic visit at no additional cost in vaccine.
引用
收藏
页码:404 / 406
页数:3
相关论文
共 13 条
[1]  
Briggs DJ, 2000, B WORLD HEALTH ORGAN, V78, P693
[2]   POSTEXPOSURE PROPHYLAXIS FOR RABIES WITH ANTISERUM AND INTRADERMAL VACCINATION [J].
CHUTIVONGSE, S ;
WILDE, H ;
SUPICH, C ;
BAER, GM ;
FISHBEIN, DB .
LANCET, 1990, 335 (8694) :896-898
[3]  
JAIGAROONSUP W, 1996, VACCINE, V16, P1559
[4]   IMMUNOGENICITY OF PURIFIED DUCK EMBRYO RABIES VACCINE (LYSSAVAC-N) WITH USE OF THE WHO-APPROVED INTRADERMAL POSTEXPOSURE REGIMEN [J].
KHAWPLOD, P ;
GLUECK, R ;
WILDE, H ;
TANTAWICHIEN, T ;
CHOMCHEY, P ;
THIPKONG, P ;
BENJAVONGKULCHAI, M ;
SUMBOONANONDHA, A ;
PRAKONGSRI, S ;
SIAKASEM, A ;
SAMRANWETAYA, P ;
YENMUANG, W ;
YOUNTONG, C ;
SUPICH, C ;
CHAIYABUTR, N ;
SITPRIJA, V .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :646-651
[5]   Rabies in Thailand [J].
Mitmoonpitak, C ;
Tepsumethanon, V ;
Wilde, H .
EPIDEMIOLOGY AND INFECTION, 1998, 120 (02) :165-169
[6]  
PHANUPHAK P, 1987, ASIAN PAC J ALLERGY, V5, P33
[7]  
SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
[8]  
*US CDC, 1990, MMWR-MORBID MORTAL W, V39, P759
[9]  
*WHO, 1992, WHO TECH REP SER, V824
[10]  
*WHO, 1996, 966 WHOEMCZOO